The Kentucky Cancer Needs Assessment (KY CNA) is a comprehensive report from a steering committee of collaborative organizations driven by the University of Kentucky Markey Cancer Center. The report combines data and community perspectives that illustrate how social determinants of health, behaviors, and biology intersect to tell the current story of cancer in Kentucky and highlights opportunities to rewrite it.

The website https://www.kycancerneeds.org/ has some valuable tools including

• Interactive Charts
• Cancer InFocus Maps
• Area Development Districts Profiles.

Tuesday, May 17, 2022

12:30-1:30 via Zoom

Ada Sue Selwtiz, MA

Executive Integrity/Compliance Advisor,

Office for the Vice President for Research and CCTS

Objective: Understand why, what, when, and how to re-consent or notify previously-enrolled participants

Monday, May 23, 2022

12-12:45 via Zoom

Meredith Duncan, PhD

Assistant Professor, Biostatistics

Biostatistics Core Coordinator, Center for Health Equity Transformation

Objective: An overview of when and how to adjust for race and ethnicity as well as guidelines for choosing when it is appropriate to not adjust for race and ethnicity.

The REC Scholars Training Program is a newly established program supported by our NIH Alzheimer’s Disease Research Center (UK-ADRC) grant P30 AG072946. The program is aimed at junior investigators (assistant professors or clinical fellows) and will provide protected time/support for junior investigators from multidisciplinary fields to pursue mentored basic, translational, or clinical research in Alzheimer’s disease (AD) and related dementias. Awards are intended to provide seed funding/ protected time that will facilitate the initial testing of novel hypotheses that lead to national-level funding of an expanded research plan based on the pilot work. Scholars will follow a customized training plan to foster career development goals with mentored support. Training will be provided in a supportive and collaborative academic environment with experienced and dedicated training faculty.  

Applicants are encouraged where possible to communicate before submission with investigators in the ADRC’s existing Cores in order to strengthen their research plan. 

• Clinical [Dr. Gregory Jicha]
• Neuropathology [Dr. Peter Nelson]
• Data Management & Statistics [Dr. Richard Kryscio]
• Outreach Recruitment & Engagement [Dr. Frederick Schmitt]
• Biomarker [Dr. Donna Wilcock]
• Research Education Component [Dr. Linda Van Eldik] 

Applications due by 11:59pm, Wednesday June 15, 2022.

Notice Number: NOT-OD-22-125

First Available Due Date: June 05, 2022

Expiration Date: July 17, 2022

Related Announcements

• PA-20-183- NIH Research Project Grant (Parent R01 Clinical Trial Required)
• PA-20-185- NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
• PA-20-200- NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)
• PA-20-194- NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required)
• PA-20-195- NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)

Issued by Office of The Director, National Institutes of Health (OD)

Purpose: Funding opportunity to advance the goals of the NIH Implementing a Maternal health and Pregnancy Outcomes Vision for Everyone (IMPROVE) Initiative. IMPROVE aims to understand the biological, behavioral, environmental, sociocultural, and structural factors that affect pregnancy-related and pregnancy-associated morbidity and mortality and build an evidence base for improved care and outcomes. The initiative promotes research to address health disparities associated with pregnancy-related and pregnancy-associated morbidity and mortality.

This notice will support the development and implementation of strategies to inform integrated efforts involving policy and practice changes to improve preconception, pregnancy, perinatal, and postpartum care and advance maternal health and maternal health equity.

Notice Number: NOT-OD-22-110

First Available Due Date: May 31, 2022

Expiration Date: June 01, 2022

Related Announcements

PA-20-272 - Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) 

Issued by

• Office of The Director, National Institutes of Health (OD)
• National Eye Institute (NEI)
• National Heart, Lung, and Blood Institute (NHLBI)
• National Institute on Aging (NIA)
• National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
• Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
• National Institute of Dental and Craniofacial Research (NIDCR)
• National Institute on Drug Abuse (NIDA)
• National Institute of Mental Health (NIMH)
• National Institute of Neurological Disorders and Stroke (NINDS)
• National Center for Complementary and Integrative Health (NCCIH)
• National Center for Advancing Translational Sciences (NCATS)

Purpose: The goal of this Notice of Special Interest (NOSI) is to provide support through administrative supplements to strengthen data management, sharing and data readiness efforts within the HEAL Initiative that further fosters collaboration among HEAL awardees and enables maximal data discoverability, interoperability, and reuse by aligning with the FAIR (Findable, Accessible, Interoperable, and Reusable) principles. This NOSI provides an opportunity for existing HEAL Initiative recipients to increase data “FAIR”-ness, participate in coordinated HEAL Initiative activities to build community around data sharing, and foster sustainability of HEAL Initiative digital assets. 

Research Objective: This Notice of Special Interest (NOSI) is meant to drive collaborative interactions and enable maximal data discoverability, interoperability, and reuse by aligning with the FAIR (Findable, Accessible, Interoperable, and Reusable) principles. This NOSI provides an opportunity for existing HEAL Initiative awardees to increase data “FAIR”-ness and participate in HEAL Initiative activities to build a community and foster sustainability of HEAL Initiative-generated data.